Citigroup’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.9M | Sell |
634,501
-4,787
| -0.7% | -$150K | 0.01% | 716 |
|
2025
Q1 | $19M | Buy |
639,288
+6,344
| +1% | +$188K | 0.01% | 731 |
|
2024
Q4 | $18.7M | Buy |
632,944
+616,912
| +3,848% | +$18.2M | 0.01% | 679 |
|
2024
Q3 | $499K | Buy |
16,032
+6,299
| +65% | +$196K | ﹤0.01% | 2987 |
|
2024
Q2 | $330K | Sell |
9,733
-12,762
| -57% | -$433K | ﹤0.01% | 2933 |
|
2024
Q1 | $1.46M | Buy |
22,495
+18,356
| +443% | +$1.19M | ﹤0.01% | 2078 |
|
2023
Q4 | $283K | Buy |
4,139
+1,148
| +38% | +$78.4K | ﹤0.01% | 3023 |
|
2023
Q3 | $155K | Sell |
2,991
-671
| -18% | -$34.8K | ﹤0.01% | 3094 |
|
2023
Q2 | $220K | Buy |
3,662
+3,322
| +977% | +$199K | ﹤0.01% | 3189 |
|
2023
Q1 | $16.8K | Sell |
340
-6
| -2% | -$297 | ﹤0.01% | 3916 |
|
2022
Q4 | $19.7K | Buy |
+346
| New | +$19.7K | ﹤0.01% | 3908 |
|